AIM Biotech

AIM Biotech is at the forefront of revolutionizing drug discovery through innovative human biology-on-a-chip technology. Recognizing the limitations of traditional animal models, AIM Biotech focuses on developing humanized, 3D in vitro systems that offer precise insights into drug efficacy and safety. Their flagship products, the organiX and idenTx platforms, enable researchers to conduct predictive human-based drug testing and study complex tissue environments like organoids and biopsies.

With a commitment to non-animal research, AIM Biotech’s solutions include the versatile idenTx microfluidic platforms, available in various formats for scalability, and the organiX system, designed for functional precision medicine. They also provide custom assay development and high-throughput screening services tailored for oncology, vascular biology, and neurobiology, thus enhancing the drug discovery process. With their focus on creating accurate and reproducible models, AIM Biotech is dedicated to accelerating the development of innovative therapies and improving clinical outcomes in personalized medicine.